Online stakeholder workshop on the state of functioning and implementation of the Council Directive 89/105/EEC relating to the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the...
Recently, a position statement was published in the Orphanet Journal of Rare Diseases by a researcher living with a rare disease, advocating for more transparency in rare disease research. In this context, “nontransparent” researcher refers to...
The Committee of Ministers adopted on 1 February 2023 a Recommendation to promote, in the 46 Council of Europe member states, equitable access to medicinal products and medical equipment in a situation of shortage and to...
Decision only available in French and Italian, on CURIA.
L’Agence nationale de sécurité des médicaments et des produits de santé (ANSM) et le Health Data Hub (HDH) signent une convention-cadre pour favoriser le partage des données dont dispose l’ANSM et l’open source tout en...
